The Effect of Probiotics ATG-F4 in Cancer Patients
Patients with advanced colorectal cancer or pancreatic cancer who are receiving oxaliplatin-based chemotherapy will be included. The research participants in this study will consume probiotics along with safety and anti-cancer agent side effect-related questionnaires, blood, and fecal sample collection for up to 12 weeks from the date of registration. The total duration of participation for research subjects is 12 weeks.
• Patients diagnosed with advanced colorectal cancer or pancreatic cancer who are undergoing treatment with Oxaliplatin-based chemotherapy at Chungnam National University Hospital, including both newly diagnosed and recurrent cases.
• Aged 19 years or older.
• Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2 points.
• Expected life expectancy of at least 3 months.
• Ability to understand the requirements of the clinical trial and willingness to sign the informed consent form.